Home > Insider Trading > Filing (0001209191-14-044401)

Filing Details

Accession Number:: 0001209191-14-044401
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2014-06-30 16:37:48
Reporting Period:: 2014-06-26

Filing Date:: 2014-06-30
Accepted Time:: 2014-06-30 16:37:48
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1009356	Salix Pharmaceuticals Ltd	SLXP	Pharmaceutical Preparations (2834)	943267443

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1212670	J Carolyn Logan	8510 Colonnade Center Drive Raleigh NC 27615	President & Ceo	Yes	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2014-06-26	33,750	$18.87	608,839	No	4	M	Direct
Common Stock	Acquisiton	2014-06-26	65,625	$18.87	674,464	No	4	M	Direct
Common Stock	Disposition	2014-06-26	19,200	$123.87	655,264	No	4	S	Direct
Common Stock	Disposition	2014-06-26	32,857	$123.13	622,407	No	4	S	Direct
Common Stock	Disposition	2014-06-26	1,000	$122.38	621,407	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	M	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Option to Buy Common Stock	Disposition	2014-06-26	33,750	$0.00	33,750	$18.87
Common Stock	Option to Buy Common Stock	Disposition	2014-06-26	65,625	$0.00	65,625	$18.87

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0		2014-07-01	No	4	M	Direct
0		2014-07-01	No	4	M	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	400,000	Indirect	By GRAT

Reported Derivative Holdings

Show Other Fields >>

Sec. Name	Sec. Type	Price	Date	Expiration Date	Amount	Remaning Holdings	Nature of Ownership
Common Stock	Option to Buy Common Stock	$17.63		2015-06-09	44,000	44,000	Direct

Expiration Date	Amount	Remaning Holdings	Nature of Ownership
2015-06-09	44,000	44,000	Direct

Footnotes

This exercise and sale was effected pursuant to a Rule 10b5-1 trading plan entered into by the reporting person on March 5, 2014.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $123.50 to $124.49, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $122.49 to $123.48, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (3) to this Form 4.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $122.28 to $122.45, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (4) to this Form 4.
Options are 100% vested.